Because phosphorylation of Tau is intimately connected to the progression of AD16, the impaired interaction of phosphorylated Tau with Hsp90/FKBP51 suggests that the interplay of Tau with Hsp90/co-chaperone complexes may vary in different stages of AD. The gene discussed is MAPT; the disease is Alzheimer disease.